Journal article
Synchrotron microbeam radiotherapy in a commercially available treatment planning system
C MPoole, LRJ Day, PAW Rogers, JC Crosbie
Biomedical Physics and Engineering Express | IOP PUBLISHING LTD | Published : 2017
Abstract
In this paperwe use a research licensed version of the Eclipse TM treatment planning system (TPS) from Varian Medical Systems, Inc. to develop a novel treatment planning environment for synchrotron microbeam radiotherapy (MRT).This research license allows for customised dose calculation algorithms to be integrated with the clinicalwork-flows in Eclipse that are typical tomodern radiotherapy. In thisway, all the functionality of the Eclipse TPS familiar tomany radiation oncology professionals is retained for application toMRT.Our TPS is designed for the dynamicMRTmodality that has been developed for the imaging and medical beamline (IMBL) at theAustralian synchrotron. TheTPS uses a very simpl..
View full abstractGrants
Awarded by National Health and Medical Research Council of Australia's Project
Funding Acknowledgements
This research project is supported by the National Health and Medical Research Council of Australia's Project Grant Scheme (APP1061772). We are grateful to Dr Crister Ceberg, Dr Per Engstrom and Ms Madeleine Holm from Lund University (Lund, Sweden) for fruitful discussions and exchanges. We also thank Dr Elke Bruuer-Krisch from the European Synchrotron Radiation Facility (Grenoble, France), Dr Trevor Ackerly from the Alfred Hospital (Melbourne, Australia) and Dr Duncan Butler from the Australian Radiation Protection and Nuclear Safety Agency (Melbourne, Australia) for their contributions to the project. We thank the reviewers of the paper for their constructive comments, critiques and suggestions.